is a cytokine that promotes the survival, proliferation, and differentiation of hematopoietic progenitors in synergy with other growth factors, such as stem cell factor. Previously we have demonstrated that stem cell factor and its receptor c-kit are expressed in neural crest-derived tumor cells and that a c-kit block induces their apoptosis. Here we have evaluated the expression of flt-3 and its ligand in 12 neuroectodermal tumor cell lines from neuroblastoma (NB), neuroepithelioma (NE), Ewing sarcoma (ES), and peripheral neuroectodermal tumor (PNET) and in 38 biopsies: 19 from NB and 19 from ES and PNET. RT-PCR demonstrated the expression of flt-3 and FL in all lines. Coexpression was observed in 42% of NB and in 74% of ES and PNET biopsies. Flow cytometry confirmed the presence of membrane and cytoplasmic flt-3 and membrane FL in all lines, whereas soluble FL protein was not measurable in their supernatants. Microphysiometric demonstration of acidification of the medium provided evidence of the specific response of cell lines to FL stimulation. Specific flt-3 phosphorylation after FL treatment was also demonstrated by Western blotting analysis. In cells growing in RPMI plus 1% fetal calf serum, FL revealed a significant proliferating activity, more evident in NB and NE lines (mean increase of viable cells, 73 Ϯ 26% after 1 day). Treatment with flt-3 antisense oligonucleotides significantly inhibited cell growth. FL also displayed an antiapoptotic activity: after a 12-hour culture in the presence of 0.1% fetal calf serum, FL caused a 50% reduction of apoptotic cells. These results provide further evidence that neuroectodermal and hematopoietic cells share common regulatory pathways, and could be of interest in the clinical management of neuroectodermal tumors. (Lab Invest 2001, 81:1025-1037.
F
lt-3 is a transmembrane glycoprotein. Like the stem cell factor (SCF) receptor (c-kit) and those for M-CSF (c-fms/FMS) and PDGF (PDGFRA and PDGFRB), it belongs to the tyrosine kinase receptor class III (Lyman et al, 1993; Rosnet et al, 1991; Shibuya et al, 1990) . Flt-3 is expressed on human hematopoietic progenitors, immature thymocytes, monocytes, acute myelogenous leukemia (AML) and B cell precursors acute lymphoblastic leukemia (ALL), mouse fetal liver, and various adult mouse tissues, such as brain and cerebellum (Birg et al 1992; Drexler et al 1999; . Its ligand, flt-3 ligand (FL), is a cytokine that promotes the proliferation, survival, and differentiation of hematopoietic progenitors (Broxmeyer et al, 1995; Hannum et al, 1994; Lyman et al, 1994; Rasko et al, 1995; Vanu et al, 1999; Zeigler et al, 1994) in synergy with other growth factors, namely SCF, IL-3, IL-6, IL-11, IL-12, and GM-CSF (Drouet et al, 1999; Jacobsen et al, 1995) . In association with G-CSF, FL mobilizes stem and progenitor cells to peripheral blood (Molineux et al, 1997; Papayannopoulou et al, 1997) . It plays an important role in lymphopoiesis (in synergy with IL-7) and in the production of dendritic cells (Hunte et al, 1996; Ohm et al, 1999; Ray et al, 1996) . All of these biological functions make FL potentially useful in various clinical settings (Lyman, 1998) .
SCF and c-kit (Bernstein et al, 1991; Yarden et al, 1987; Zsebo et al, 1990) are involved in development of the peripheral nervous system and are expressed in neural crest-derived tumor cells (Cohen et al, 1994) . c-kit block induces neuroectodermal tumor cell apoptosis (Ricotti et al, 1998 (Ricotti et al, , 1999 Timeus et al, 1997) . Neural and hematopoietic cells are closely correlated and "hematopoietic" growth factors such as FL are active in the generation of neural cells from bone marrow mesenchymal stem cells (Reyes and Verfaillie, 1999) .
SCF and FL synergize in the regulation of hemopoiesis (Lyman and Jacobsen, 1998) . The role of FL/flt-3 alone and its possible cooperation with SCF/c-kit in the biology of neuroectodermal tumors are investigated in this study.
Results
RT-PCR analysis demonstrated the expression of flt-3 and FL RNA in all 12 lines (Fig. 1 ). Flt-3 RNA was expressed in 14 of 19 neuroblastoma (NB) and 17 of 19 Ewing sarcoma (ES) and peripheral neuroectodermal tumor (PNET) biopsies; FL was expressed in 9 of 19 NB and in 14 of 19 ES and PNET biopsies. Flt-3/FL coexpression was observed in 42% of NB biopsies and in 74% of ES and PNET biopsies (Table 1, Fig. 2 ).
Flow cytometry showed the presence of membrane and cytoplasmic flt-3 and membrane FL in all lines (Fig. 3) , whereas soluble FL protein (evaluated by ELISA) was not measurable. Cell lines responded to FL stimulation by acidifying the medium in a concentration-dependent manner, as demonstrated by the cytosensor (Fig. 4) ; the peak rate was reached after about 2 minutes at 2,500 ng/10 6 cells FL concentration.
Inhibition of the receptor-response by pretreating the FL preparation with a suitable concentration of specific FL-neutralizing antibody provided the evidence for cytokine/receptor-specific activity (Fig. 5) . Specific flt-3 phosphorylation after FL treatment was demonstrated by using Western blotting analysis on flt-3 immunoprecipitates (Fig. 6) .
When the lines were cultured in medium supplemented with 1% fetal calf serum (FCS), the presence of FL significantly (p Ͻ 0.005) increased the number of viable cells (evaluated by trypan blue exclusion) after 1 to 3 days of culture (Table 2 , Fig. 7 ). This activity was more evident in NB and NE lines (mean increase vs controls, 73 Ϯ 26% after one day and 50 Ϯ 23% after 3 days). The association FL ϩ SCF showed an additive effect. Treatment with flt-3 and c-kit antisense oligonucleotides specifically inhibited cell growth from the sixth day. After a 9-day culture in the presence of flt-3 antisense, cellular flt-3 expression decreased (data not shown) and there was a 45% specific reduction of viable cells (Table 3 , Fig. 8 ).
FL showed a significant antiapoptotic activity in the experiments at 0.1% FCS: after a 12-hour culture, FL caused a 50% reduction of apoptotic cells, as demonstrated by flow cytometry for annexin V (Table 4 , Fig. 9 ). SCF showed a similar behavior. FL ϩ SCF had the same antiapoptotic effect as the single cytokines.
Discussion
FL and SCF are cytokines that play a crucial role in regulation of the early phases of hemopoiesis. They protect stem cells from apoptosis and, in cooperation with other growth factors, promote the proliferation of hemopoietic progenitors. Their activities on these progenitors mostly overlap, but are often synergic. Many data point to the existence of a relatively early progenitor coexpressing c-kit and flt-3. Hematopoietic and nervous systems have a similar differentiation pathway from a stem cell to various final elements. Recent data suggest the existence of a common stem cell that can alternatively differentiate to the hematopoietic or nervous direction: donor-derived hematopoietic cells develop in sublethally irradiated mice transplanted with neural stem cells (Bjornson et al, 1999) and marrow cells differentiate into microglia and macroglia (Eglitis and Mezey, 1997) . We have previously demonstrated that the system SCF/c-kit is expressed in primitive neuroectodermal tumors and exerts an in We now show that neural crest-derived tumors express both flt-3 and FL m-RNA. Their lines also express membrane and cytoplasmic flt-3 protein and FL protein in a membrane-bound form. This is probably the first demonstration that flt-3 and its ligand are expressed in neural crest-derived tumor cell lines. PCR performed on biopsies substantiates our results by giving them biological significance and ruling out aberrations of cell lines.
The expression of FL/flt-3 and SCF/c-kit in neural crest-derived tumor cells and their proliferative and antiapoptotic activity provide further evidence that hematopoietic and neural progenitors share common regulatory systems (Quesenberry et al, 1999; SieberBlum, 1998) . Whereas in neuroectodermal tumor cell lines, c-kit expression decreases according to differentiation, as in the hemopoietic progenitors, and is lowest in the more differentiated neuroblastoma lines (Ricotti et al, 1998; Timeus et al, 1997) , flt-3 expression is similar in ES, PNET, and neuroblastoma lines and is thus unrelated to differentiation of neural progenitors.
Proliferation and apoptosis experiments demonstrated a functional role of FL/flt-3 in the regulation of these tumor lines. In cultures with a suboptimal FCS concentration (1%), addition of FL significantly increased the number of viable cells from the first day. The increase was higher after 1 than after 3 days, probably because of the increasing number of cells per well. In these experimental conditions, FL showed a direct proliferating activity, whereas its antiapoptotic effect was negligible (not shown). Confirmation of the role of flt-3 in the proliferation of neuroectodermal tumor cells was provided by the demonstration that flt-3 antisense oligonucleotides significantly reduced the number of viable cells from the sixth culture day. In the experiments with very low FCS concentration (0.1%), FL also showed a significant antiapoptotic activity, like SCF, with a 50% reduction of apoptotic cells after a 12-hour culture.
As previously discussed, SCF and FL often show a synergic activity on the hematopoietic progenitors. In the neuroectodermal tumor cell lines, their association displayed an additive rather than a synergic effect in the proliferation assays, whereas its antiapoptotic effect was the same as that of the single cytokines. This may reflect the existence of a threshold of maximal antiapoptotic activity. Similar results were observed when cultures were carried out in the presence of antisense oligonucleotides and in cytosensor experiments in which flt-3 ϩ SCF caused the same acidification as that of the single cytokines (not shown).
The in vitro proliferative and antiapoptotic activity of FL/flt-3 was negligible in standard culture conditions (10% FCS) in which other factors presumably hold cell viability and proliferation at an optimal level.
FL protein was only present in a membrane-bound form in the cell lines and its soluble form was undetectable in their supernatants; this could be attributed to a rapid self-utilization of FL from cells or to a very low FL level in the supernatants, not detected by our method. FL/flt-3 coexpression in most lines and tumors points to an autocrine loop mediated by cell-tocell interactions. This mechanism could be more substantial in ES and PNET than in NB and NE (FL/flt-3 coexpression in 74% and 42% of biopsies, respectively) and certainly plays a favorable role in tumor proliferation. Only further experiments on normal human tissues can clarify whether it is a causal factor in tumor transformation.
All biopsies were obtained from stage III and IV tumors. The prognostic value of FL/flt-3 expression is under investigation.
In conclusion, our data demonstrate that FL and flt-3 are expressed in neuroectodermal tumors and in neuroblastoma where they exert a biological activity by promoting the survival and proliferation of tumor cells. The clinical usefulness of these data needs further investigation. The fact that hemopoietic growth factors stimulate neuroectodermal tumor cells provides further evidence of a common ancestral precursor for neuroectodermal and hematopoietic cells. FL mobilizes hematopoietic progenitors and promotes dendritic cell production and is therefore potentially suitable for cancer therapy. Our data suggest that its clinical use in neural crest-derived tumors ought to be cautiously evaluated.
Materials and Methods

Cell Lines
Twelve tumor cell lines of neuroectodermal origin: six NB and NE lines (IMR-5, SK-N-SH, SK-N-BE, AF8, SJ-N-KP, CHP-100), three ES lines (6647, TC106, PDE02), and three PNET lines (PDN12, PDN13, TC32) (Biedler et al, 1973 (Biedler et al, , 1978 Pagani et al, 1998; Rocchi et al, 1987; Schlesinger et al, 1976; Thiele et al, 1987) were cultured in RPMI 1640 (GIBCO, Grand Island, New York) plus 10%, 1%, or 0.1% FCS (Irvine, Santa Ana, California). The TC32 cell line was used only for molecular studies. As controls, the M-07E line (Avanzi et al, 1990) was maintained in Iscove's modified Dulbecco's medium (GIBCO) supplemented with 5% FCS and rhGM-CSF (Sandoz, Basel, Switzerland) 150 U/ml, and K-562, 5637, and HL60 lines were cultured in RPMI 1640 plus 10% FCS.
Supernatants for ELISA were obtained by culture at 5 ϫ 10 4 cells/ml. The conditioned medium was removed after 72 hours, centrifuged, filtered, and assayed.
Biopsies
Nineteen biopsies from stage III and IV NB (kindly provided by Dr. G. P. Tonini, Genova) and 19 biopsies from ES and PNET (all with the chimeric fusion gene product EWS/FLI1, kindly provided by Dr. E. Frascella, Padova) were analyzed. All diagnoses were confirmed by a reference team of Italian Pediatric Hematology and Oncology Association (AIEOP) pathologists.
RT-PCR Analysis
Total RNA was extracted by the guanidine salts and phenol-chloroform method (Ultraspec RNA; Biotecx 
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Laboratories, Houston, Texas). cDNA was prepared from 2 g of total RNA, using poly-T as primer and MMLV reverse transcriptase (GeneAmp RNA PCR Kit; Perkin Elmer, Foster City, California). PCR was performed in a Perkin Elmer GeneAmp PCR System 9700, using one-fourth of the reverse transcription product and 25 pmol of each oligonucleotide as primers. After one denaturation step at 96°C for 3 minutes, 35 cycles of amplification were performed: denaturation at 94°C for 1 minute, annealing at 65°C or 69°C (for flt-3 and FL, respectively) for 1 minute, synthesis at 72°C for 1 minute, and extension at 72°C for 5 minutes. Oligonucleotides for flt-3 expression analysis were: sense primer 5'-CAAGTGC-TGTGCATACAATTCCC-3' (positions 1536 -1558 on the sequence), antisense primer 5'-ACCTGTACCATCT-GTAGCTGG-3' (positions 1722-1742) ; oligonucleotides for FL were: sense primer 5'-TGTCAGCCCGACTCCTCAACC-3' (positions 555-575) and antisense primer 5'-AGTGCTCCACAAGCAG-CAGGT-3' (positions 769 -789) (Lisovsky et al, 1996) . To check cDNA quality, beta-actin was amplified using sense primer 5'-CCACTGGCATCGTGATGGACT-3' and antisense primer 5'-TCCTTCTGCATCCTGTCGGC-3' (Ponte et al, 1984) .
One-tenth of the amplified products was run on 2% agarose gels in 1ϫ Tris borate buffer and visualized with ethidium bromide. The M07-E and K-562 lines were used as negative controls for FL and flt-3, respectively. 5637 and HL60 were the positive controls. Cytosoft rate window demonstrating the dose-response curve of SJ-N-KP cells exposed to FL. Concentrations (in ng/10 6 cells): 0 (orange), 1.25 (dark blue), 12.5 (red), 125 (green), 1,250 (black), 2,500 (light blue), 5,000 (purple). Acidification peaked at 2,500 ng FL/10 6 cells. The arrow indicates the time at which growth factor was added. Time: minutes, 1 V/sec ϭ 1 millipH/minute.
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Enzyme Immunoassay for Soluble FL Protein
Soluble FL protein was determined according to the manufacturer's instructions by ELISA (Quantikine; R & D Systems, Minneapolis, Minnesota) in conditioned medium of NB, NE, ES, and PNET lines cultured for 72 hours. Briefly, 96-well microtiter plates coated with a murine monoclonal antibody against FL were used. One hundred microliters of assay diluent were added to each well, then FL standards and samples (50 l) were added and incubated for 2 hours at room temperature. After washing, an enzyme-linked polyclonal antibody specific for FL (200 l) was added for 1.5 hours. Two hundred microliters of peroxidase substrate were added and incubated for 20 minutes at room temperature. Absorbance was read at 450 nm with a Microplate Reader (Bio-Rad Laboratories, Milan, Italy). The minimum detectable concentration of FL was 7 pg/ml. The control was RPMI 1640 medium.
Flow Cytometry Evaluation of Flt-3 and FL Expression
Cell lines were tested for the presence of surface flt-3 and FL and cytoplasmic flt-3. Scraped cells (2 ϫ 10 5 ) were incubated with 5 l anti-flt-3 PE-conjugated BV10A4H2 (Caltag, San Francisco, California) for 20 minutes at 4°C, then washed with PBS plus 1% w/v bovine serum albumin before analysis with a flow cytometer EPICS XL (Coulter, Miami Lake, Florida) equipped with an argon laser. Isotype PE conjugate was used as negative control. To detect cytoplasmic flt-3, cells were incubated according to the manufacturer's instructions in 100 l fixing solution (Fix and Perm Cell permeabilization kit; Caltag) for 15 minutes at room temperature, washed in PBS, resuspended in permeabilizing solution in the presence of 5 l PEconjugated BV10A4H2, incubated for 15 minutes at room temperature, and then washed and analyzed as described. Cord blood CD34ϩ cells and K-562 cells were used as the positive and negative control, respectively. Surface FL expression was investigated by indirect flow cytometry using anti-FL 40406.111 MoAb (R & D Systems, Milan, Italy) as primary antibody and goat antimouse F(ab)2 FITC-conjugated MoAb (Technogenetics, Milan, Italy) as secondary antibody. The M07-E line was used as negative control.
Cytosensor Experiments
An innovative instrument, the microphysiometer "Cytosensor" (Molecular Devices, Sunnyvale, California), which measures the ligand/receptor reaction from the output of acid from cells (McConnell et al 1992; Salon and Owicki, 1994) , was used to study the response to FL stimulation of SJ-N-KP and PDN12 cell lines. Cells 
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in RPMI 1640 were seeded into cytosensor capsule cups 18 hours before the experiment. The capsules were then transferred into a silicon-containing sensor chamber. The instrument measures the rate of output of acid from cells (acidification rate); the fluid flow is periodically halted to allow a build-up of acid metabolites in the chamber. Determination of the baseline acidification rate from eight replicate chambers after normalizing data was followed by introduction of the effector agent, and its effect on the acidification rate was monitored. The FL working concentration was calculated from a dose-response curve in which the cells were incubated for 6 minutes with 0, 1.25, 12.5, 125, 1,250, 2,500, and 5,000 ng FL/10 6 cells. Acidification peaked with FL 2500 ng/10 6 cells. This concentration was used to demonstrate ligand-receptor specificity by adding an anti-FL neutralizing antibody (R & D Systems) at 25,000 ng/10 6 cells. Synergy between FL and SCF was evaluated in other experiments that compared SCF (500 ng/10 6 cells) with FL ϩ SCF.
Proliferation Assays
NB, NE, ES, and PNET cell lines were cultured (2 ϫ 10 4 /ml) in RPMI 1640 plus 1% FCS with or without 50 ng/ml recombinant human FL, 50 ng/ml recombinant human SCF, 50 ng/ml FL ϩ 50 ng/ml SCF (R and D Systems), alone and associated with 0.5 g/ml anti-FL (40406.111 MoAb, R and D Systems) and 20 g/ml anti-SCF (goat IgG polyclonal Ab; R & D Systems) neutralizing antibodies. Cultures were also performed in the presence of 50 ng/ml IL-2, as negative control. Cytokines and antibodies were added every day. After 24, 48, and 72 hours, cells were trypsinized and viable cells were counted by trypan blue exclusion in a Neubauer chamber. All assays were performed in triplicate. The increase in the number of cells was determined by comparison with day zero.
In further experiments, cells cultured in RPMI 1640 ϩ 10% FCS were exposed to phosphorothioate antisense oligonucleotide for flt-3, c-kit, flt-3ϩc-kit (4 M; TIB MOLBIOL, Genova, Italy; flt-3 antisense sequence: 5'-CXTXgX CXgXCX CXAXAX CXgXCX CXCXgX CXAXT; c-kit antisense sequence: 5'-gXCXCX gXCXgX AXgXCX gXCXCX TXCXTX CXAXT; Xϭ phosphorothioate modification), according to previously described methods (Ricotti et al, 1998) , for 3, 6, and 9 days. The uptake of FITC-conjugated antisense oligonucleotides had been previously determined. An example is shown in Figure 10 . Antisense oligonucleotides were added to cultures every day. Cultures with sense and randomized-sequence phosphorothioate oligonucleotides were also performed. The K562 line was used as negative control. After 3, 6, and 9 days, cells were trypsinized and viable cells were counted by trypan blue exclusion. The increase in the number of viable cells was calculated by comparison with day zero. The specific inhibition of cell growth was determined as the difference between cell growth inhibition caused by antisense and sense oligonucleotides.
Evaluation of Apoptosis
Apoptosis of NB, NE, ES, and PNET cells cultured (2 ϫ 10 4 /ml) in RPMI 1640 plus 0.1% FCS with or without 50 ng/ml FL, 50 ng/ml SCF, 50 ng/ml FL ϩ 50 ng/ml SCF for 72 hours was evaluated by flow cytometry, using annexin V-FITC conjugates (Apoptosis Detection Kits; R and D Systems), according to the manufacturer's instructions. Briefly, cells were first washed with PBS containing calcium and then incubated for 15 minutes at room temperature with 0.025 g annexin V-FITC and 0.5 g propidium iodide before analysis with a EPICS XL2 flow cytometer. All of the experiments were performed in triplicate. Cytospin preparations were stained with May GrunwaldGiemsa for morphologic evaluation of apoptotic cells.
Immunoprecipitation Studies
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were resuspended in RPMI medium supplemented with 0.1% FCS, incubated for 24 hours at 37°C in 5% CO 2 , then untreated and FL-treated cells (10 minutes with 50 ng/2 ϫ 10 4 cells) were rapidly pelleted and resuspended in lysis buffer (10 mM Tris-HCl, pH 8.6, 1.5 mM MgCl 2 , 0.14 M NaCl, 1% NP40, 2 mM phenylmethylsulfonylfluoride, 2 g/ml leupeptin, 2 g/ml aprotinin, 1 mg/ml pepstatin A). Lysates were incubated for a minimum of 30 minutes on ice, frozen, thawed, and centrifuged at 13,000 rpm at 4°C for 20 minutes. Immunoprecipitation of flt-3 was performed on the clarified supernatant with a rabbit polyclonal antihuman flt-3 (Santa Cruz Biotechnology, Santa Cruz, California) after 1 hour of rotation at 4°C. Protein A-Agarose (Santa Cruz Biotechnology) was added and the rotation was prolonged for 16 hours at 4°C. Immunoprecipitates were than washed twice with lysis buffer, once with lysis buffer without NP-40, and once Proliferation assays in SJ-N-KP, PDE02, and PDN12 lines. Cells were cultured for 24, 48, and 72 hours in RPMI 1640 plus 1% FCS in the presence or absence of 50 ng/ml FL, 50 ng/ml SCF, 50 ng/ml FL ϩ 50 ng/ml SCF, and 50 ng/ml IL-2 as negative control. After trypsinization, viable cells were counted by trypan blue exclusion in a Neubauer chamber. Y axis, cell number; CL, control.
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Figure 8.
Proliferation assays in NBϩNE, ES, and PNET lines after 3-, 6-, and 9-day cultures in RPMI 1640 with 10% FCS (CL, control) or RPMI 1640 with 10% FCS plus 4 M phosphorothioate antisense oligonucleotide for flt-3 (flt-3 A), sense oligonucleotides for flt-3 (flt-3 S), and randomized-sequence phosphorothioate oligonucleotides (R). The oligonucleotides were added to cultures every day. After trypsinization, viable cells were counted by trypan blue exclusion in a Neubauer chamber. Data express the mean of the results of the experiments performed with five NB and NE lines, three ES lines, and three PNET lines. The K562 line was used as negative control. Y axis, cell number. 
Statistical Analysis
Statistics were obtained with Student's paired t test.
Figure 10.
Cytospin demonstrating the oligonucleotide uptake of the SJ-N-KP cell line cultured in RPMI 1640 ϩ 10% FCS for 48 hours with 4 M FITC phosphorothioate antisense oligonucleotide for flt-3.
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